Emma Walmsley, GSK CEO (Credit: Fang Zhe/Xinhua/Alamy Live News)
August 22, 2022 12:31 PM EDTUpdated August 23, 06:18 AM
Pharma
Law

GSK to SCO­TUS: Don't take up 'skin­ny' gener­ic drug la­bel case

Zachary Brennan

Senior Editor

GSK made clear to the US Supreme Court on Fri­day that it should not re­vive its case against Te­va Phar­ma­ceu­ti­cals re­gard­ing so-called “skin­ny” gener­ic drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times